SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950115-00-001050
Filing Date
2000-08-22
Accepted
2000-08-22 00:00:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A 0001.txt SC 13D/A 41078
2 STOCK PURCHASE AGREEMENT 0002.txt EX-8 153013
3 REGISTRATION RIGHTS AGREEMENT 0003.txt EX-10 75074
4 AMENDMENT NO. 1 TO STOCKHOLDERS' AGREEMENT 0004.txt EX-11 10071
5 AMENDMENT TO RESTATED REGISTRATION RIGHTS AGREE. 0005.txt EX-12 7930
  Complete submission text file 0000950115-00-001050.txt   290299
Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address 30831 HAYWARD AVE HAYWARD CA 94544 2152892220
IMPAX LABORATORIES INC (Filed by) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address 30831 HAYWARD AVE HAYWARD CA 94544 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 707560
SIC: 2834 Pharmaceutical Preparations